A key linear epitope for a potent neutralizing antibody to SARS-CoV-2 S-RBD

Tingting Li(Tianjin University), Aishun Jin(Chongqing Medical University), Qian Chen(The Affiliated Yongchuan Hospital of Chongqing Medical University), Jingjing Huang(Chongqing Medical University), Guiji Zhang(Chongqing Medical University), Ailong Huang(Chongqing Medical University), Wei Xu(Beijing Geriatric Hospital), Yingyi Long(Chongqing Medical University), Yaru Nai(Chongqing Medical University), Song Mu, Shunhua Long(Chongqing Medical University), Kai Wang(Xinjiang Medical University), Xiaojian Han(Chongqing Medical University), Shuyi Song(Chongqing Medical University), Feiyang Luo(Zhujiang Hospital), Yang Wu(Wuhan University), Fang Gong(Chongqing Emergency Medical Center), Meiying Shen, Ni Tang(Ho Chi Minh City University of Education), Zhenghong Yuan(Shanghai Medical College of Fudan University), Jianwei Wang(Zhejiang Cancer Hospital), Jie Hu(People's Hospital of Kaizhou District), Youhua Xie(Shanghai Medical College of Fudan University), Li Luo(Chongqing Medical University), Yingming Wang(China Pharmaceutical University), Wang Wang(Nanchang University), Chenjian Gu(Washington University in St. Louis), Xia Cai(Fudan University), Shenglong Li(Chongqing Medical University), Yanan Hao(North China University of Science and Technology), Kun Deng(Central South University), Changlong He(Army Medical University), Fengxia Gao(Chongqing Medical University), Qingzhu Gao(MRC Laboratory of Molecular Biology), Di Qu(Xijing Hospital), Chao Hu(Central South University), Rui‐Xin Wu(Air Force Medical University), Li Du(Chongqing Medical University)
bioRxiv (Cold Spring Harbor Laboratory)
September 11, 2020
Cited by 7


Related Papers